Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Non Operating Income: 2010-2020

Historic Non Operating Income for Niagen Bioscience (NAGE) over the last 8 years, with Jun 2020 value amounting to -$24,000.

  • Niagen Bioscience's Non Operating Income rose 95.83% to -$24,000 in Q2 2020 from the same period last year, while for Jun 2020 it was -$343,000, marking a year-over-year increase of 34.91%. This contributed to the annual value of -$847,000 for FY2019, which is 488.19% down from last year.
  • According to the latest figures from Q2 2020, Niagen Bioscience's Non Operating Income is -$24,000, which was down 100.00% from -$12,000 recorded in Q1 2020.
  • Niagen Bioscience's Non Operating Income's 5-year high stood at $746,000 during Q3 2017, with a 5-year trough of -$575,000 in Q2 2019.
  • In the last 3 years, Niagen Bioscience's Non Operating Income had a median value of -$18,000 in 2020 and averaged -$102,700.
  • As far as peak fluctuations go, Niagen Bioscience's Non Operating Income soared by 266.36% in 2017, and later tumbled by 3,388.89% in 2019.
  • Quarterly analysis of 5 years shows Niagen Bioscience's Non Operating Income stood at -$18,360 in 2016, then tumbled by 139.83% to -$44,033 in 2017, then soared by 149.96% to $22,000 in 2018, then slumped by 68.18% to $7,000 in 2019, then spiked by 95.83% to -$24,000 in 2020.
  • Its Non Operating Income was -$24,000 in Q2 2020, compared to -$12,000 in Q1 2020 and $7,000 in Q4 2019.